20 results
424B3
CTCX
Carmell Therapeutics Corporation
5 Jun 24
Prospectus supplement
6:06am
to be used in chronic wound care and aesthetic applications and is similar in formulation to BHA minus one material, ß-TCP. The form of these two
425
fhhcr vqv
6 Jul 23
Business combination disclosure
5:15pm
8-K
EX-99.1
7ylhihm7d5ilat
6 Jul 23
Other Events
5:11pm
424B3
spx5m4 majirvzj
23 Jun 23
Prospectus supplement
4:47pm
10-K
wbdl zace
15 Apr 22
Annual report
5:11pm
424B4
51azl5uq8 ik
27 Jul 21
Prospectus supplement with pricing info
10:42am
S-1
cmo2msv3b1gngjf
4 Mar 21
IPO registration
4:01pm
DRS
0qbrlm3i5wstoxm 11
2 Feb 21
Draft registration statement
12:00am
- Prev
- 1
- Next